BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hong B, Sahu U, Mullarkey MP, Kaur B. Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors. Viruses 2022;14:118. [PMID: 35062322 DOI: 10.3390/v14010118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hong B, Sahu U, Mullarkey MP, Hong E, Pei G, Yan Y, Otani Y, Banasavadi-Siddegowda Y, Fan H, Zhao Z, Yu J, Caligiuri MA, Kaur B. PKR induces TGF-β and limits oncolytic immune therapy. J Immunother Cancer 2023;11. [PMID: 36796878 DOI: 10.1136/jitc-2022-006164] [Reference Citation Analysis]
2 Hu H, Xia Q, Hu J, Wang S. Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects. J Clin Med 2022;11. [PMID: 36498574 DOI: 10.3390/jcm11236997] [Reference Citation Analysis]
3 Chai C, Zhang J, Zhou Y, Yin H, Zhang F, Diao Y, Zan X, Ma Y, Wang Y, Wu Y, Wang W. The Effects of Oncolytic Pseudorabies Virus Vaccine Strain Inhibited the Growth of Colorectal Cancer HCT-8 Cells In Vitro and In Vivo. Animals 2022;12:2416. [DOI: 10.3390/ani12182416] [Reference Citation Analysis]
4 Rice SA. Special Issue “Replication and Spread of Alphaherpesviruses”. Viruses 2022;14:1652. [DOI: 10.3390/v14081652] [Reference Citation Analysis]
5 Kalke K, Orpana J, Lasanen T, Esparta O, Lund LM, Frejborg F, Vuorinen T, Paavilainen H, Hukkanen V. The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1. Viruses 2022;14:1290. [PMID: 35746761 DOI: 10.3390/v14061290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rivera-Caraballo KA, Nair M, Lee TJ, Kaur B, Yoo JY. The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics. Mol Ther Oncolytics 2022;26:63-75. [PMID: 35795093 DOI: 10.1016/j.omto.2022.05.013] [Reference Citation Analysis]
7 Otani Y, Yoo JY, Shimizu T, Kurozumi K, Date I, Kaur B. Implications of immune cells in oncolytic herpes simplex virotherapy for glioma. Brain Tumor Pathol 2022. [PMID: 35384530 DOI: 10.1007/s10014-022-00431-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Malliou A, Kyritsis AP, Alexiou GA. Immunotherapeutic Strategies for Glioma Treatment. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_71] [Reference Citation Analysis]